Soley Therapeutics Announces $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform by Jessica | Jan 7, 2026 Read more »
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator by Jessica | Dec 5, 2025 Read more »
Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a New Class of Therapeutic Targets with Structural Surfaceomics by Jessica | Sep 18, 2025 Read more »
Corsair Pharma to Present New Data on Proprietary Treprostinil Prodrug Transdermal System at PHPN 2025 Symposium by Jessica | Sep 15, 2025 Read more »
Glycomine Initiates Dosing in a Global, Randomized, Placebo-Controlled Phase 2b Study of GLM101 for the Treatment of PMM2-CDG by Jessica | Sep 3, 2025 Read more »
